Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
4 hedge funds and large institutions have $1.86M invested in Viking Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
187% more capital invested
Capital invested by funds: $648K → $1.86M (+$1.21M)
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$529K |
| 2 |
US Bancorp
Minneapolis,
Minnesota
|
+$15.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
Top Sellers
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$230K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
William Blair & Company
Chicago,
Illinois
| $1.02M | +$529K | +101,025 | +396% |
|
|
PWAM
2
Park West Asset Management
San Francisco,
California
| $773K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $41K | +$10.2K | +1,944 | +62% |
|
|
4
US Bancorp
Minneapolis,
Minnesota
| $24K | +$15.7K | +3,000 | New |
|
|
5
DZ Bank
Frankfurt Am Main,
Germany
| – | -$230K | -74,285 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$43K | -14,012 | Closed |
|
VKTXW Hedge Fund Activity: Q2 2018 in Review
4 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q2 2018, worth a combined $1.86M — up 187% from $648K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VKTXW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was William Blair & Company, adding an estimated $529K. The largest seller was DZ Bank, exiting entirely with an estimated $230K sold.
- 4 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q2 2018, down from 6 in Q1 2018.
- Funds reported $1.86M of Viking Therapeutics, Inc. stock for Q2 2018, up 187% quarter-over-quarter.
- 1 fund opened new Viking Therapeutics, Inc. positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest Viking Therapeutics, Inc. buyer in Q2 2018 was William Blair & Company, an estimated $529K added.
- The largest Viking Therapeutics, Inc. seller in Q2 2018 was DZ Bank, an estimated $230K sold.
Based on aggregated 13F filings for Q2 2018.